International Clinical Trial: Predictive Factors for the Impact of Matrix-Type Fentanyl Patches on Immunotherapy Efficacy in Cancer Pain Patients

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132776) titled 'Predictive Factors for the Impact of Matrix-Type Fentanyl Patches on Immunotherapy Efficacy in Cancer Pain Patients' on Sept. 18.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: Xuzhou Central Hospital

Condition: Cancer Cancer Pain

Intervention: Non-cancer pain group:None The cancer pain group and the low-dose matrix-type fentanyl transdermal patch group.:None

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2025-05-18

Target Sample Size: Non-cancer pain group:60;The cancer pain group and the low-dose matrix-type fentanyl transdermal patch grou...